MML Investors Services’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,610
Closed -$607K 2572
2024
Q2
$607K Sell
6,610
-1,522
-19% -$141K ﹤0.01% 1660
2024
Q1
$749K Sell
8,132
-55
-0.7% -$5.15K ﹤0.01% 1578
2023
Q4
$778K Buy
+8,187
New +$765K ﹤0.01% 1501
2023
Q3
Sell
-4,748
Closed -$434K 2298
2023
Q2
$434K Buy
+4,748
New +$390K ﹤0.01% 1722
2023
Q1
Sell
-5,128
Closed -$428K 2051
2022
Q4
$428K Buy
5,128
+69
+1% +$6.22K ﹤0.01% 1582
2022
Q3
$490K Buy
5,059
+71
+1% +$8.47K ﹤0.01% 1440
2022
Q2
$524K Sell
4,988
-85
-2% -$10.9K ﹤0.01% 1385
2022
Q1
$874K Buy
5,073
+459
+10% +$68.6K 0.01% 1156
2021
Q4
$747K Buy
4,614
+1,693
+58% +$272K 0.01% 1198
2021
Q3
$436K Sell
2,921
-211
-7% -$43.9K ﹤0.01% 1435
2021
Q2
$767K Buy
3,132
+642
+26% +$168K 0.01% 1124
2021
Q1
$659K Buy
2,490
+706
+40% +$199K 0.01% 1123
2020
Q4
$523K Buy
1,784
+439
+33% +$113K 0.01% 1136
2020
Q3
$318K Buy
+1,345
New +$306K ﹤0.01% 1251

Other funds holding AMED

MML Investors Services's AMED Position: Q3 2024 in Review

MML Investors Services sold out of Amedisys (AMED) in Q3 2024, closing a stake of 6,610 shares — an estimated $607K sold.

MML Investors Services first reported a position in AMED in Q3 2020 and held it in 14 quarters. The position peaked at $874K in Q1 2022. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • MML Investors Services reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • MML Investors Services sold 6,610 Amedisys shares in Q3 2024, an estimated $607K.
  • MML Investors Services first reported a position in Amedisys in Q3 2020 and held it in 14 quarters.
  • MML Investors Services's Amedisys position peaked at $874K in Q1 2022.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on MML Investors Services's 13F filing for Q3 2024, filed 15 Nov 2024.